scholarly journals Correction to: Predictors of improvement in resting heart rate after exercise training in patients with chronic obstructive pulmonary disease

2021 ◽  
Author(s):  
İlknur Naz ◽  
Hülya Şahin ◽  
Büşra Aktaş
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Heart Rate ◽  
Exercise Training ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Resting Heart Rate ◽  
Obstructive Pulmonary Disease

scholarly journals Resting Heart Rate Is a Risk Factor for Mortality in Chronic Obstructive Pulmonary Disease, but Not for Exacerbations or Pneumonia

PLoS ONE ◽  
2014 ◽  
Vol 9 (8) ◽  
pp. e105152 ◽  
Author(s):  
Miriam J. Warnier ◽  
Frans H. Rutten ◽  
Anthonius de Boer ◽  
Arno W. Hoes ◽  
Marie L. De Bruin
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Heart Rate ◽  
Risk Factor ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Resting Heart Rate ◽  
Obstructive Pulmonary Disease

scholarly journals Effects of Aerobic Exercise Training and Irbesartan on Blood Pressure and Heart Rate Variability in Patients with Chronic Obstructive Pulmonary Disease

2008 ◽  
Vol 15 (7) ◽  
pp. 355-360 ◽  
Author(s):  
Karine Marquis ◽  
François Maltais ◽  
Yves Lacasse ◽  
Yves Lacourcière ◽  
Claudette Fortin ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Chronic Obstructive Pulmonary Disease ◽  
Heart Rate ◽  
Heart Rate Variability ◽  
Placebo Group ◽  
Exercise Training ◽  
Pulmonary Disease ◽  
Aerobic Exercise Training ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease

BACKGROUND AND OBJECTIVES: The present pilot study was undertaken to evaluate the efficacy of an aerobic exercise training (AET) program alone or combined with an antihypertensive agent (irbesartan) to reduce blood pressure (BP) and enhance heart rate variability (HRV) in chronic obstructive pulmonary disease patients.METHODS: Twenty-one patients were randomly assigned to a double-blind treatment with exercise and placebo (n=11) or exercise and irbesartan (n=10). Subjects underwent 24 h BP monitoring and 24 h electrocardiographic recording before and after the 12-week AET. HRV was investigated using three indexes from the power spectral analysis and three indexes calculated from the time domain. The AET program consisted of exercising on a calibrated ergocycle for 30 min three times per week. Five patients in the placebo group were excluded during follow-up because they were not compliant.RESULTS: There was no change in 24 h systolic and diastolic BP before (130±14 mmHg and 70±3 mmHg, respectively) and after (128±8 mmHg and 70±8 mmHg, respectively) exercise training in the placebo group, whereas in the irbesartan group systolic and diastolic BP decreased from 135±9 mmHg and 76±9 mmHg to 126±12 mmHg and 72±8 mmHg, respectively (P<0.02). There were no changes in HRV parameters in either group.CONCLUSIONS: The present study suggests that a 12-week AET program is not associated with a significant reduction in BP or enhancement in HRV, whereas an AET program combined with irbe-sartan is associated with a reduction in 24 h BP.

Influence of resting heart rate on chronic obstructive pulmonary disease

2019 ◽  
Author(s):  
A Omlor ◽  
FC Trudzinski ◽  
M Alqudrah ◽  
F Seiler ◽  
F Biertz ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Heart Rate ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Resting Heart Rate ◽  
Obstructive Pulmonary Disease
Sign in / Sign up

Export Citation Format

Share Document